10% oxytetracycline injection
each ml contains Oxytetracycline 100 mg.
Oxytetracycline injection is a wide spectrum bacteriostatic antibiotic. It acts on gram-positive and gram-negative micro-organisms. It is particularly sensitive to streptococci, clostridia, E.coli, shigellae, brucellae, salmonellae, leptospirae. Etc. In addition, it is effective against some mycoplasmas, rickettsiae, chlamydiae, some protozoa and large viruses. After administration of therapeutic dose of Oxytetracycline injection 5%, a high level of Oxytetracycline in blood is achieved within half an hour to 4 hours.
Treatment of diseases caused by Oxtetracycline-susceptible organisms in cattle, sheep and goats. Diseases including pneumonia and shipping fever complex associated with Pasteur ella spp and Haemophilus spp, infectious bovine kerato-conjunctivitis ( pinkeye ) caused by Moraxella bovis, foot rot and diphtheria caused by Fusobacterium necrophorum, bacterial enteritis ( scours) caused by Escherichia coli, wooden tongue caused by Actinobacillus lignierisii; leptospirosis caused by Leptospira pomoma; wound infections and acute metritis caused by strains of staphylocci and streptococci organisms sensitive to Oxytetracycline.
For cattle: Bronchopneumonia and other respiratory infections, infections of the gastrointestinal tract, metritis, mastitis, septicaemia, puerperal infections, and secondary bacterial infections primarily caused by viruses, etc
For sheep and goats: Infections of respiratory, urogenital, gastrointestinal tract and hooves, mastitis, infected wounds, etc.
Pharmacological action: N/A
Usage and administration:
Administer by intramuscular injection. The dose of the active principle Oxytetracy-cline amounts to 10 mg/kg bodyweight of the animal. Administer for 3 – 5 days depending on the type and severity of the infection. The administration is carried out in the following volume:
Cattle 2ml / 10 kg bodyweight
Calves 2ml / 10 kg bodyweight
Sheep and goats 2ml / 10 kg bodyweight
Pigs 2ml / 10 kg bodyweight
Side effect and contraindication:
Oxtetracycline injection 5% is not intended for cats, dogs and horses. It should not be given to animals in late pregnancy, animals with severe damages of liver and kidneys and to animals oversensitive to Oxytetraycline.
Sometimes a temporary swelling on the injection site occurs.
Withdrawal time: From last treatment, within 21 days for meat and edible tissues and within 7 days for milk.
Storage and expired time: In a cool dry place under 25 centi-degrees, away from light.
Packing : 50ml, 100ml, 250ml/bottle
Одну корову за 15дней по инструкции ветеринара Бер!ккали вылечили от модулярного дерматита, из-за чего объявили карантин и поставили полицейский пост, 15 уколов бицилин-5, асд-2 и асд-3, нитокс и мыл с мылом корову. На природе в глуши речного острова вблиз Каспия держим коров и растим плодовые и виноград, слушаем сердце природы.
Rheumatoid arthritis affects 1 in 100 Australians. It is a major cause of disability and psychological distress due to its chronic, painful and disabling character. Rheumatoid arthritis, an inflammatory autoimmune disease, is the second most common type of arthritis after osteoarthritis. The disease is more common amongst women and in the older age groups. Untreated rheumatoid arthritis can result in joint damage and deformities. The disease impacts on activities of daily living, capacity to work, and family life. Early diagnosis and medical intervention are critical to limiting structural damage and improving health outcomes.
The Clinical Guideline for Diagnosis and Management of Early Rheumatoid Arthritis presents recommendations to assist and support clinical judgement of GPs in managing patients with rheumatoid arthritis. This program, in line with the Guideline, focuses on diagnosis, early management, and coordination of multidisciplinary care needs for people with rheumatoid arthritis. Pharmacological and non-pharmacological interventions are reviewed. The Clinical Guideline recognises the need for every patient with rheumatoid arthritis to have a thorough assessment of their individual needs; access to a range of health professionals; and a comprehensive care plan.
This program is one of four in the Musculoskeletal Guideline Series. The Royal Australian College of General Practitioners (RACGP) has developed national musculoskeletal clinical guidelines for general practitioners and other primary care health professionals for osteoarthritis, rheumatoid arthritis, juvenile idiopathic arthritis and osteoporosis.
Produced by the Rural Health Education Foundation